JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
CBIO Financials - Crescent Biopharma Income & Cash Flow | Ledgeburg
CBIO - Crescent Biopharma, Inc.
USD | NASDAQ | Healthcare
Summary
Summary CBIO Stock
Financials
Financials CBIO Stock
Loading...
Loading...
Income Statement
Income Statement CBIO Stock
Balance Sheet
Balance Sheet CBIO Stock
Cash Flow Statement
Cash Flow Statement CBIO Stock
Loading...
Loading...
Home
Stocks
Crescent Biopharma, Inc. (CBIO)
Financials
Financials of CBIO
Loading...
Loading...
Loading...
Loading...
Revenue
$10.844M
Operating Income
$-152.632M
Net Income
$-153.942M
Share Count (Basic)
N/A
Operating Cash Flow
$-71.532M
Free Cash Flow
$-72.451M
Cash And Short-Term Equivalents
$213.192M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
2M
4M
6M
8M
10M
FY2021
FY2022
FY2023
FY2025
Revenue $USD
0
200K
400K
600K
800K
1M
Q1 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-150M
-100M
-50M
FY2021
Annual
Quarterly
Margins
Gross
Operating
Net
-400000%
-300000%
-200000%
-100000%
0%
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-100M
-80M
-60M
-40M
-20M
0
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-2400%
-2350%
-2300%
-2250%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26